BioNTech SE BNTX
NASDAQ BNTX
$96.90 +0.05 (+0.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Gains from Investment Securities (2021 - 2023)

Updated

BioNTech SE (BNTX) recorded Gains from Investment Securities of $82.98 million in Q2 2023, down 10.1% from $92.3 million a year earlier.

Analysis

BioNTech SE (BNTX) Gains from Investment Securities (2021 - 2023) Analysis & Trends

On a TTM basis, BioNTech SE's Gains from Investment Securities came in at $210.21 million as of Jun 30, 2023; for FY2021, it was $65.55 million.

  • The Q2 2023 figure is the lowest quarterly Gains from Investment Securities since Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 BioNTech SE 24.50 Bn -34.86 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 82.98 Mn
Jun 30, 2022 92.30 Mn
Mar 31, 2022 -2.13 Mn
Dec 31, 2021 37.06 Mn
API Access

BioNTech SE Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=BNTX&period=max&api_key=YOUR_API_KEY